Foscavir (Clinigen Healthcare Ltd.)


Welcome to the PulseAid listing for the Foscavir drug offered from Clinigen Healthcare Ltd.. This DNA Polymerase Inhibitors [MoA],Pyrophosphate Analog [Chemical/Ingredient],Pyrophosphate Analog DNA Polymerase Inhibitor [EPC],Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Clinigen Healthcare Ltd.
NON-PROPRIETARY NAME: foscarnet sodium
SUBSTANCE NAME: FOSCARNET SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: DNA Polymerase Inhibitors [MoA],Pyrophosphate Analog [Chemical/Ingredient],Pyrophosphate Analog DNA Polymerase Inhibitor [EPC],Chelating Activity [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2014-04-01
END MARKETING DATE: 0000-00-00


Foscavir HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFoscavir from Clinigen Healthcare Ltd.
LABELER NAME: Clinigen Healthcare Ltd.
DEA SCHEDULE:
ACTIVE STRENGTH: 24(mg/mL)
START MARKETING DATE: 2014-04-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 76310-024_00ca4075-719d-4657-82f4-423d7ac5b148
PRODUCT NDC: 76310-024
APPLICATION NUMBER: NDA020068

Other FOSCARNET SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Clinigen Healthcare Ltd.Foscavir